Meritage Portfolio Management »

Catalyst Pharmaceutical Partners shares owned by Meritage Portfolio Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Meritage Portfolio Management from 13F filings

Historical chart of Meritage Portfolio Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Meritage Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Meritage Portfolio Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $305k 19k 15.93
2022-12-31 $195k 11k 18.60

More positions owned by Meritage Portfolio Management

Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Inc Cl A Common (GOOGL)
Broadcom Common (AVGO)
Amazon Common (AMZN)
Novo-nordisk A S Common (NVO)
Asml Holding Nv Common (ASML)
Cadence Design Systems Common (CDNS)
Fortinet Common (FTNT)
Cheniere Energy Common (LNG)
Pioneer Nat Res Common (PXD)
Mastercard Common (MA)
Spdr S&p 500 Value Etf Other Equities (SPYV)
Ametek Common (AME)
Kla Corporation Common (KLAC)

View all positions for Meritage Portfolio Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners